IL22 and ovarian carcinoma: Protection of the intestine by gavage of LR-IL-22 between radiation fractions of WAI may afford an opportunity to increase the irradiation dose for WAI in Ovarian cancer and other disseminated abdominal cancers such as peritoneal mesothelioma, abdominal carcinoid tumors, and colon cancer.